// App-Quantinova.ai

143 : Real world treatment patterns of previously treated advanced gastric and gastroesophageal junction adenocarcinoma (GC) in Mexico.

Researchers

Presenter

  • Kyla Jones

Principal Investigators

  • JUAN ALEJANDRO SILVA

  • Diego Novick

  • Brenda S Botello

  • Brbara Monroy Cruz

  • JM Iglesias-Chiesa

  • Miguel Quintana

Medical Centers

  • T.I. Salud, Mexico City, Mexico

  • Centro Medico Nacional Siglo XXI, Mexico City, Mexico

  • Eli Lilly and Company, Windlesham, United Kingdom

  • Eli Lilly and Company, Mexico City, Mexico

  • Zeed Pharmaceutical Solutions, Mexico City, Mexico

Locations

  • Mexico

  • United Kingdom

Companies

  • EMB Statistical Solu

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastroesophageal junction (GEJ) adenocarcinoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved